| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M308600200 |
| P698 | PubMed publication ID | 14594814 |
| P2093 | author name string | Paula B Tracy | |
| Jay R Silveira | |||
| Weston R Gould | |||
| P2860 | cites work | Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain | Q24290716 |
| Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats | Q24310656 | ||
| O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats | Q24310686 | ||
| Tyrosine phosphorylation regulates alpha II spectrin cleavage by calpain | Q24537349 | ||
| Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Replacement of m-calpain by mu-calpain during maturation of megakaryocytes and possible involvement in platelet formation | Q33361222 | ||
| Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency | Q33478715 | ||
| A simple method for the preparation of homogeneous phospholipid vesicles | Q34405356 | ||
| Isolation and study of an acquired inhibitor of human coagulation factor V. | Q34520485 | ||
| Isolation of functional human coagulation factor V by using a hybridoma antibody | Q35302079 | ||
| Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol | Q36105481 | ||
| Structural characterization of site-specific N-glycosylation of recombinant human factor VIII by reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry | Q36885148 | ||
| Activation of coagulation factor V by a platelet protease | Q36987960 | ||
| Human coagluation factor V purification and thrombin-catalyzed activation | Q37028310 | ||
| Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin | Q37041393 | ||
| Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V modulates assembly of the prothrombinase complex. | Q38320989 | ||
| Thrombin-Catalyzed Activation of Recombinant Human Factor V | Q41358432 | ||
| Posttranslational sulfation of factor V is required for efficient thrombin cleavage and activation and for full procoagulant activity | Q45873172 | ||
| Preparation of suspensions of washed platelets from humans. | Q53992379 | ||
| The activation of bovine coagulation factor X | Q55032927 | ||
| Activation of prothrombin with (taipan snake) venom | Q59319157 | ||
| A rapid sensitive silver stain for polypeptides in polyacrylamide gels | Q60628142 | ||
| Massive hemorrhage associated with circulating antibodies to factor V | Q67246123 | ||
| Hemorrhagic death associated with a high titer factor V inhibitor | Q67363748 | ||
| Prothrombin | Q68236963 | ||
| Expression and characterization of recombinant human factor V and a mutant lacking a major portion of the connecting region | Q68913493 | ||
| Factor V | Q70233554 | ||
| Structural comparison of a 15 residue peptide from the V3 loop of HIV-1IIIb and an O-glycosylated analogue | Q71548810 | ||
| The Mechanism of Inactivation of Human Platelet Factor Va from Normal and Activated Protein C-resistant Individuals | Q72017113 | ||
| Partial glycosylation of Asn2181 in human factor V as a cause of molecular and functional heterogeneity. Modulation of glycosylation efficiency by mutagenesis of the consensus sequence for N-linked glycosylation | Q73082870 | ||
| Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor | Q73144463 | ||
| Protein C activation and factor Va inactivation on human umbilical vein endothelial cells | Q73965821 | ||
| Identification and partial characterization of factor Va heavy chain kinase from human platelets | Q74393024 | ||
| Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding | Q77153299 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2383-2393 | |
| P577 | publication date | 2003-10-31 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va | |
| P478 | volume | 279 |
| Q40025300 | A unique function for LRP-1: a component of a two-receptor system mediating specific endocytosis of plasma-derived factor V by megakaryocytes |
| Q33372831 | Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004. |
| Q34404185 | Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation. |
| Q35126279 | Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation |
| Q36301525 | Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice |
| Q33748551 | Comparative response of platelet fV and plasma fV to activated protein C and relevance to a model of acute traumatic coagulopathy |
| Q53458479 | Effect of five therapeutic strategies on the coagulation defect induced by the thrombomodulin c.1611C>A mutation. |
| Q45302089 | Endocytosis of plasma-derived factor V by megakaryocytes occurs via a clathrin-dependent, specific membrane binding event |
| Q35149917 | Exploration of the host haemostatic system by group A streptococcus: implications in searching for novel antimicrobial therapies |
| Q33376731 | Factor Va, bound to microparticles released during platelet storage, is resistant to inactivation by activated protein C. |
| Q36713533 | Genotype-phenotype correlation in combined deficiency of factor V and factor VIII. |
| Q34353691 | Identification of the MMRN1 binding region within the C2 domain of human factor V. |
| Q36367017 | Inherited defects of coagulation factor V: the hemorrhagic side. |
| Q60049563 | LC-MS/MS analysis of the dog serum phosphoproteome reveals novel and conserved phosphorylation sites: Phosphoprotein patterns in babesiosis caused by Babesia canis, a case study |
| Q45856641 | Laparoscopic surgery in a woman with factor V deficiency: revisiting platelet factor V. |
| Q45862385 | Management of bleeding in severe factor V deficiency with a factor V inhibitor |
| Q53573313 | Mechanisms Regulating Acquisition of Platelet-Derived Factor V/Va by Megakaryocytes. |
| Q39407960 | Novel role for galectin-8 protein as mediator of coagulation factor V endocytosis by megakaryocytes |
| Q37487079 | Platelet alpha-granules: basic biology and clinical correlates |
| Q64974497 | Platelet protein S directly inhibits procoagulant activity on platelets and microparticles. |
| Q38281989 | Platelet secretion: From haemostasis to wound healing and beyond |
| Q41627505 | Platelet-Derived Factor V Is a Critical Mediator of Arterial Thrombosis |
| Q26820857 | Platelet-based coagulation: different populations, different functions |
| Q35692419 | Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency |
| Q37196840 | Platelets: developmental biology, physiology, and translatable platforms for preclinical investigation and drug development. |
| Q34304738 | Polyphosphate modulates blood coagulation and fibrinolysis. |
| Q35166026 | Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase |
| Q37100189 | Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool. |
| Q34667573 | Prothrombin activation on the activated platelet surface optimizes expression of procoagulant activity |
| Q34084997 | Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients. |
| Q37086949 | Reduced thrombin generation increases host susceptibility to group A streptococcal infection |
| Q37233988 | Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides |
| Q37116951 | Systemic blood coagulation activation in acute coronary syndromes |
| Q52338988 | TAILS N-Terminomics and proteomics reveal complex regulation of proteolytic cleavage by O-glycosylation. |
| Q33711510 | The factor V light chain mediates the binding and endocytosis of plasma-derived factor V by megakaryocytes |
| Q34358555 | The molecular basis of factor V and VIII procofactor activation |
Search more.